Lateralized ante mortem and post mortem pathology in a case of Lewy body disease with corticobasal syndrome
Abstract Introduction Lewy body diseases are pathologically characterized by α‐synuclein pathology. Alzheimer's disease (AD) co‐pathology can influence phenotypes. In vivo AD biomarkers can suggest the presence of this co‐pathology in unusual cases, but pathological validation remains essential...
Saved in:
| Main Authors: | David G. Coughlin, H. Branch Coslett, Claire Peterson, Jeffrey S. Phillips, Corey McMillan, Edward B. Lee, John Q. Trojanowski, Murray Grossman, David J. Irwin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/trc2.12294 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
by: D. Luke Fischer, et al.
Published: (2025-01-01) -
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies
by: Fernando L. Pagan, et al.
Published: (2022-01-01) -
Cognitive decline profiles associated with lewy pathology in the context of Alzheimer’s disease neuropathologic change
by: Jon B. Toledo, et al.
Published: (2024-12-01) -
Novel approaches targeting α-Synuclein for Parkinson's Disease: Current progress and future directions for the disease-modifying therapies
by: David Baggett, et al.
Published: (2024-12-01) -
Altered cortical network dynamics during observing and preparing action in patients with corticobasal syndrome
by: Marius Krösche, et al.
Published: (2025-02-01)